Raymed Labs (BOM:531207) Total Liabilities : ₹33.95 Mil (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Raymed Labs Total Liabilities?

Raymed Labs's Total Liabilities for the quarter that ended in Dec. 2024 was ₹33.95 Mil.

Raymed Labs's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹35.90 Mil) but then declined from Sep. 2024 (₹35.90 Mil) to Dec. 2024 (₹33.95 Mil).

Raymed Labs's annual Total Liabilities increased from Mar. 2022 (₹23.81 Mil) to Mar. 2023 (₹24.62 Mil) and increased from Mar. 2023 (₹24.62 Mil) to Mar. 2024 (₹25.58 Mil).

Raymed Labs Total Liabilities Historical Data

The historical data trend for Raymed Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raymed Labs Total Liabilities Chart

Raymed Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

22.41

23.05

23.81

24.62

25.58

Raymed Labs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	25.58	-	35.90	33.95

Raymed Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Raymed Labs's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.266	+	(0	+	24.317
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	25.58

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	1.508	-	-24.075
	=	25.58

Raymed Labs's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.234	+	(32.713	+	-0.0010000000000048
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	33.95

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	7.038	-	-26.908
	=	33.95

Raymed Labs Total Liabilities Related Terms

Thank you for viewing the detailed overview of Raymed Labs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Raymed Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raymed Labs Ltd (BOM:531207) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

C-273, Sector-63, Noida, UP, IND, 201301

Website

https://www.raymedlab.com

Raymed Labs Ltd is an Indian company engaged in the business of pharmaceutical sector. The company is involved in manufacturing as well as trading medicines and chemicals. Business operations activities include; manufacturers and producers, buyers and sellers, trading, stores and stockists, suppliers and distributors, wholesale and retail dealers in pharmaceuticals, medicals, chemicals, industrial and other preparations and articles, compounds, drugs, veterinary and human medicines, and others.

Raymed Labs Headlines

No Headlines